相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis
Yvonne Benesova et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation
Silvia Rossi et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Daclizumab Therapy for Multiple Sclerosis
Bibiana Bielekova
NEUROTHERAPEUTICS (2013)
Natalizumab Therapy for Multiple Sclerosis
Jeremy Chataway et al.
NEUROTHERAPEUTICS (2013)
Brain dendritic cells: biology and pathology
Paul M. D'Agostino et al.
ACTA NEUROPATHOLOGICA (2012)
Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
New and emerging disease modifying therapies for multiple sclerosis
Shiv Saidha et al.
YEAR IN IMMUNOLOGY (2012)
Induced CD4+Foxp3+ Regulatory T Cells in Immune Tolerance
Angelina M. Bilate et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
The emerging multiple roles of nuclear Akt
Alberto M. Martelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab
Luisa Klotz et al.
CLINICAL IMMUNOLOGY (2012)
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis
Roland Martin
CLINICAL IMMUNOLOGY (2012)
Treatment of multiple sclerosis with Anti-CD20 antibodies
Barbara Barun et al.
CLINICAL IMMUNOLOGY (2012)
Helper T cell diversity and plasticity
Shingo Nakayamada et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics
Kelly C. Simon et al.
CURRENT OPINION IN NEUROLOGY (2012)
Regulatory T cells in the central nervous system
Daniel E. Lowther et al.
IMMUNOLOGICAL REVIEWS (2012)
Immune checkpoints in central nervous system autoimmunity
Nicole Joller et al.
IMMUNOLOGICAL REVIEWS (2012)
Type17 T-cells in Central Nervous System Autoimmunity and Tumors
Hideho Okada et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Multiple sclerosis
Alyssa Nylander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa- generated induced Foxp3+ T reg cells
Jonathan M. Weiss et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis Optica
Zhihua Ren et al.
JOURNAL OF IMMUNOLOGY (2012)
A Novel IL-10-Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand
Avijit Ray et al.
JOURNAL OF IMMUNOLOGY (2012)
IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis
Meiyue Chen et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations
Petra Praksova et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
Extrathymically generated regulatory T cells control mucosal TH2 inflammation
Steven Z. Josefowicz et al.
NATURE (2012)
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Ayumi Yoshizaki et al.
NATURE (2012)
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS
S. Marousi et al.
NEUROLOGY (2012)
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL
Valerie Rigau et al.
NEUROLOGY (2012)
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
Britta Engelhardt et al.
TRENDS IN IMMUNOLOGY (2012)
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
Laura Lovato et al.
BRAIN (2011)
Glatiramer Acetate in the Treatment of Multiple Sclerosis Emerging Concepts Regarding its Mechanism of Action
Patrice H. Lalive et al.
CNS DRUGS (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
Mario Skarica et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse
Evelyn Peelen et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission
Stephanie Knippenberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Biomarkers of disease activity in multiple sclerosis
Jerome J. Graber et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Maturation of effector regulatory T cells
Naganari Ohkura et al.
NATURE IMMUNOLOGY (2011)
Foxo: in command of T lymphocyte homeostasis and tolerance
Weiming Ouyang et al.
TRENDS IN IMMUNOLOGY (2011)
Neurological S1P Signaling as an Emerging Mechanism of Action of Oral FTY720 (Fingolimod) in Multiple Sclerosis
Chang Wook Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Regulatory T cells: The suppressor arm of the immune system
Sheila Langier et al.
AUTOIMMUNITY REVIEWS (2010)
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
Joanne L. Jones et al.
BRAIN (2010)
Understanding the development and function of T follicular helper cells
Roza I. Nurieva et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Overlapping and distinct mechanisms of action of multiple sclerosis therapies
J. J. Graber et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Developmental plasticity of Foxp3(+) regulatory T cells
Shohei Hori
CURRENT OPINION IN IMMUNOLOGY (2010)
Human regulatory T cells in autoimmune diseases
Gregory L. Cvetanovich et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Vitamin D: modulator of the immune system
Femke Baeke et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis
Tilman Schneider-Hohendorf et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
T Regulatory Cells Maintain Intestinal Homeostasis by Suppressing γδ T Cells
Sung-Gyoo Park et al.
IMMUNITY (2010)
B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
Sara A. J. Thompson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Regulatory B cells Evidence, developmental origin and population diversity
Gaetano Vitale et al.
MOLECULAR IMMUNOLOGY (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner
NATURE REVIEWS IMMUNOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Effector and regulatory B cells: modulators of CD4+ T cell immunity
Frances E. Lund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Pathogenic CD8+ T Cells in Multiple Sclerosis
Manuel A. Friese et al.
ANNALS OF NEUROLOGY (2009)
Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg
Leigh A. Stephens et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
The Sphingosine 1-Phosphate Receptor Agonist FTY720 Potently Inhibits Regulatory T Cell Proliferation In Vitro and In Vivo
Anna Maria Wolf et al.
JOURNAL OF IMMUNOLOGY (2009)
Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis
Juergen Haas et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis
Evert-Jan Kooi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica
Wei Li et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis
Danielle Burger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation
Todd Brusko et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis
Richard A. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
Sven Jarius et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions
M. Krumbholz et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Interferon beta-1a therapy enhances CD4(+) regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis
Clara de Andres et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Increased frequency of CD4(+) CD25(+) regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients
U. Feger et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
Manoj Kumar et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A unified theory of central tolerance in the thymus
YJ Liu
TRENDS IN IMMUNOLOGY (2006)
The window of therapeutic opportunity in multiple sclerosis
AJ Coles et al.
JOURNAL OF NEUROLOGY (2006)
The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity
E Sawicka et al.
JOURNAL OF IMMUNOLOGY (2005)
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
J Haas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling
LM D'Cruz et al.
NATURE IMMUNOLOGY (2005)
Regulatory T cells: Development, function and role in autoimmunity
RY Lan et al.
AUTOIMMUNITY REVIEWS (2005)
Decreased FOXP3 levels in multiple sclerosis patients
J Huan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3
J Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
R Setoguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period
AL Bayer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy
SA Shelburne et al.
AIDS (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Myelin proteolipid protein-specific CD4+ CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis
J Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cutting edge:: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis
AP Kohm et al.
JOURNAL OF IMMUNOLOGY (2002)
The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
B Becher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The CD45 tyrosine phosphatase regulates Campath-1H (CD52)-induced TCR-dependent signal transduction in human T cells
RA Hederer et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
